DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced today that Frederick O. Cope, Ph.D. will be joining Neoprobe Corporation as its Vice President of Pharmaceutical Research and Clinical Development.
